USA Financial Formulas’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-212
Closed -$16.9K 428
2025
Q3
$16.9K Buy
212
+72
+51% +$6.14K ﹤0.01% 253
2025
Q2
$12.7K Buy
+140
New +$12.8K ﹤0.01% 237
2025
Q1
Sell
-2,334
Closed -$212K 294
2024
Q4
$212K Sell
2,334
-12,792
-85% -$1.22M 0.03% 159
2024
Q3
$1.57M Sell
15,126
-1,581
-9% -$161K 0.24% 24
2024
Q2
$1.62M Buy
16,707
+10,719
+179% +$989K 0.26% 25
2024
Q1
$539K Buy
5,988
+1,630
+37% +$138K 0.09% 91
2023
Q4
$347K Buy
+4,358
New +$328K 0.06% 110
2022
Q3
$2K Hold
31
﹤0.01% 168
2022
Q2
$2K Hold
31
﹤0.01% 194
2022
Q1
$2K Buy
+31
New +$2.46K ﹤0.01% 225
2021
Q2
Sell
-17
Closed -$1K 382
2021
Q1
$1K Sell
17
-16,026
-100% -$1.26M ﹤0.01% 292
2020
Q4
$1.37M Buy
16,043
+1,326
+9% +$110K 1.08% 27
2020
Q3
$1.14M Buy
14,717
+14,701
+91,881% +$1.12M 0.86% 43
2020
Q2
$1K Buy
+16
New +$1.14K ﹤0.01% 153

Other funds holding CL

USA Financial Formulas's CL Position: Q4 2025 in Review

USA Financial Formulas sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 212 shares — an estimated $16.9K sold.

USA Financial Formulas first reported a position in CL in Q2 2020 and held it in 14 quarters. The position peaked at $1.62M in Q2 2024. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • USA Financial Formulas reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
  • USA Financial Formulas sold 212 Colgate-Palmolive shares in Q4 2025, an estimated $16.9K.
  • USA Financial Formulas first reported a position in Colgate-Palmolive in Q2 2020 and held it in 14 quarters.
  • USA Financial Formulas's Colgate-Palmolive position peaked at $1.62M in Q2 2024.
  • 1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on USA Financial Formulas's 13F filing for Q4 2025, filed 14 Jan 2026.